Showing results (271-280 of 282) with videos related to

Sort By:
Pageof 29
Plos One|November 3, 2020
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance studyLuigi Francesco Iannone, Luigi Bennardo, Caterina Palleria, et al.
Epilepsia|August 14, 2024
Adjunctive cenobamate in people with focal onset seizures: Insights from the Italian Expanded Access ProgramRoberta Roberti, Giovanni Assenza, Francesca Bisulli, et al.
Current Medical Research and Opinion|June 24, 2020
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern ItalyRoberta Roberti, Luigi Francesco Iannone, Caterina Palleria, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 6, 2019
Hypertension, seizures, and epilepsy: a review on pathophysiology and managementSara Gasparini, Edoardo Ferlazzo, Chiara Sueri, et al.
Expert Review of Neurotherapeutics|July 2, 2019
Microbiota-gut brain axis involvement in neuropsychiatric disordersLuigi Francesco Iannone, Alberto Preda, Hervé M Blottière, et al.
Neurology and Therapy|November 20, 2025
Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar EfficacyRoberta Roberti, Cristina Politi, Francesca Anzellotti, et al.
Epilepsia|December 5, 2023
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE studyRoberta Roberti, Gianfranco Di Gennaro, Francesca Anzellotti, et al.
JAMA Neurology|February 9, 2026
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal EpilepsyEmanuele Cerulli Irelli, Roberta Roberti, Maria Sole Borioni, et al.
Epilepsia|October 29, 2025
Lennox-Gastaut syndrome unveiled: Advancing diagnosis, therapies, and advocacy-insights from the Genoa International WorkshopAntonella Riva, Gianluca D'Onofrio, Elisabetta Amadori, et al.
Pageof 29